Nature Hot Topic

Immunotherapy in advanced Ebola virus disease

This study shows that ZMapp, an optimized cocktail of three monoclonal antibodies that has been pressed into clinical use in response to the current Ebola virus disease epidemic, was able to rescue all of 18 rhesus macaques when treatment was initiated up to five days post-infection. All three controls had died by day eight.

Related articles

Recent Hot Topics

Sign up for Nature Research e-alerts to get the lastest research in your inbox every week.

PrivacyMark System